Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

23,967 total articles

AEON Biopharma Designates Former FDA Neuroscience Leader Paul Lee, M.D., Ph.D. as Acting Chief Regulatory Officer

AEON Biopharma Designates Former FDA Neuroscience Leader Paul Lee, M.D., Ph.D. as Acting Chief Regulatory Officer

AEON Biopharma, listed on NYSE American as AEON, has named Paul Lee, M.D., Ph.D., former Deputy Director at the FDA's Office of Neuroscience, as acting Chief Regulatory Officer. Dr. Lee, who has been advising AEON on regulatory strategy via Clintrex Research LLC, will now lead the company’s interactions with the FDA and oversee the regulatory roadm…

Erasca Granted FDA Fast Track Designation for Pan-RAS Molecular Glue ERAS-0015 in Patients with Metastatic Pancreatic Adenocarcinoma

Erasca Granted FDA Fast Track Designation for Pan-RAS Molecular Glue ERAS-0015 in Patients with Metastatic Pancreatic Adenocarcinoma

Erasca, Inc. announced that the FDA has granted Fast Track Designation to its investigational drug ERAS-0015 for metastatic pancreatic adenocarcinoma. The designation is based on promising Phase 1 data demonstrating clinical activity and tolerability in multiple tumor types, including pancreatic and lung cancers. The company plans three potentially…

TTEC RealSkill™ Wins Gold for Best Use of AI for Learning at 2026 Brandon Hall Group™ HCM Excellence Awards

TTEC RealSkill™ Wins Gold for Best Use of AI for Learning at 2026 Brandon Hall Group™ HCM Excellence Awards

TTEC Holdings, Inc. has been awarded the Gold award in the 2026 Brandon Hall Group HCM Excellence Awards for their RealSkill AI-Driven Workforce Readiness program. The program uses AI-powered simulations and personalized coaching to help employees practice and improve customer interaction skills. This recognition highlights TTEC's leadership in app…

Datacentrex Secures Colocation Capacity and Set to Expand Mining Fleet by More Than 500 Additional ElphaPex DG2 Miners

Datacentrex Secures Colocation Capacity and Set to Expand Mining Fleet by More Than 500 Additional ElphaPex DG2 Miners

Datacentrex, Inc. has secured colocation capacity for deployment of more than 500 prepaid ElphaPex DG2 Scrypt ASIC miners, expected to be energized within 30 days. This expansion will increase the company's aggregate hashrate by approximately 21%, improving fleet energy efficiency without additional capital expenditure. The deployment aligns with i…

NANO Nuclear and Tillman Digital Gateway Sign Strategic Commercial Framework to Enable Advanced Nuclear Power for Gigawatt-Scale U.S. AI Industrial Zones

NANO Nuclear and Tillman Digital Gateway Sign Strategic Commercial Framework to Enable Advanced Nuclear Power for Gigawatt-Scale U.S. AI Industrial Zones

NANO Nuclear Energy Inc. announced a strategic commercial framework agreement with Tillman Global Holdings to provide advanced nuclear reactor technology to power Tillman's planned gigawatt-scale AI industrial zones across the U.S. The companies aim to deploy 2 GW or more of advanced nuclear capacity by the mid-2030s and 6 GW or more by 2040, utili…

Liminatus Pharma Engages Synex as Contract Research Organization to Support Phase 1/2a Clinical Development of CD19xCD22 bivalent CAR-T therapy

Liminatus Pharma Engages Synex as Contract Research Organization to Support Phase 1/2a Clinical Development of CD19xCD22 bivalent CAR-T therapy

Liminatus Pharma has engaged Synex Consulting Ltd. as the contract research organization to conduct Phase 1/2a clinical trials of its investigational CD19xCD22 bivalent CAR-T therapy (IBC101) targeting relapsed or refractory diffuse large B-cell lymphoma (DLBCL). The engagement supports clinical trial execution in South Korea following regulatory a…

Merlin Designated a New Zealand Part 146 Aircraft Design Organization, Advancing Its Path to Commercial Operations

Merlin Designated a New Zealand Part 146 Aircraft Design Organization, Advancing Its Path to Commercial Operations

Merlin, Inc., an aerospace and defense technology company specializing in autonomous flight systems, has received the Part 146 Aircraft Design Organization certificate from the Civil Aviation Authority of New Zealand. This certification authorizes Merlin's engineers to approve certain aircraft design changes internally, reducing reliance on externa…

Crane NXT Announces Appointment of Jason Lund as President of Crane Payment Innovations and Group President of the Detection and Traceability Technologies Segment

Crane NXT Announces Appointment of Jason Lund as President of Crane Payment Innovations and Group President of the Detection and Traceability Technologies Segment

Crane NXT, a global industrial technology company, has appointed Jason Lund as President of Crane Payment Innovations and Group President of its Detection and Traceability Technologies segment. Lund brings extensive experience in leading industrial technology businesses and will focus on growth, operational excellence, and customer innovation withi…

Arbutus Commences US$230 Million Modified “Dutch Auction” Tender Offer of its Common Shares at a Price Not Greater Than US$5.75 Nor Less Than US$5.00 Per Share

Arbutus Commences US$230 Million Modified “Dutch Auction” Tender Offer of its Common Shares at a Price Not Greater Than US$5.75 Nor Less Than US$5.00 Per Share

Arbutus Biopharma Corp. announced a modified Dutch auction tender offer to repurchase up to $230 million of its common shares, representing approximately 20.2% to 23.2% of outstanding shares. The offer price range is $5.00 to $5.75 per share, funded from cash on hand following a $178 million settlement payment from Moderna. The tender offer provide…

BridgeBio to Present New Acoramidis Data from Open-Label Extension Analyses in ATTR-CM at ESC Congress 2026

BridgeBio to Present New Acoramidis Data from Open-Label Extension Analyses in ATTR-CM at ESC Congress 2026

BridgeBio Pharma announced the presentation of new data on acoramidis, its oral transthyretin stabilizer for treating transthyretin amyloid cardiomyopathy (ATTR-CM), at the ESC Congress 2026. The data reinforce acoramidis as the first-line treatment choice, highlighting survival benefits, improved myocardial functions, and enhanced quality of life.…

Gogoro Inc. Announces Retirement of Chief Financial Officer and Appointment of Principal Financial Officer

Gogoro Inc. Announces Retirement of Chief Financial Officer and Appointment of Principal Financial Officer

Gogoro Inc., a leader in battery-swapping electric mobility and a Nasdaq-listed company, announced the retirement of its longtime Chief Financial Officer Bruce Aitken effective September 1, 2026. Jacky Lee, with extensive experience in finance and operations, has been appointed as the new Principal Financial Officer. Leadership expressed confidence…

Gemini and Apex Fintech Solutions Collaborate to Bring Gemini’s Regulated Crypto Prediction Markets to Apex's Distribution Network

Gemini and Apex Fintech Solutions Collaborate to Bring Gemini’s Regulated Crypto Prediction Markets to Apex's Distribution Network

Gemini and Apex Fintech Solutions have signed a letter of intent for Gemini to become the exclusive CFTC-regulated venue for crypto event contracts distributed through Apex's Futures Commission Merchant to its brokerage clients. This collaboration leverages Gemini’s regulatory milestones to enable brokering both crypto and potentially other event c…

Monte Rosa Therapeutics Announces First Patient Dosed in MODeFIRe-1, a Phase 2 Study of MRT-2359 in Combination with Apalutamide in Patients with AR Mutation-Positive Metastatic Castration-Resistant Prostate Cancer

Monte Rosa Therapeutics Announces First Patient Dosed in MODeFIRe-1, a Phase 2 Study of MRT-2359 in Combination with Apalutamide in Patients with AR Mutation-Positive Metastatic Castration-Resistant Prostate Cancer

Monte Rosa Therapeutics has dosed the first patient in the MODeFIRe-1 Phase 2 clinical trial evaluating its investigational drug MRT-2359 combined with apalutamide in patients with AR mutation-positive metastatic castration-resistant prostate cancer (mCRPC). This follows encouraging Phase 1/2 data showing promising clinical responses in this diffic…

Descartes Acquires Tai

Descartes Acquires Tai

Descartes Systems Group has acquired Tai, an AI-powered transportation management platform for freight brokers, for approximately $100 million. The acquisition enhances Descartes' transportation management offerings and expands its Global Logistics Network with advanced freight brokerage solutions. Tai’s platform automates freight operations and su…

Rapport Therapeutics to Host Virtual KOL Event on the Unmet Need in Bipolar Mania and the RAP-219 Clinical Program

Rapport Therapeutics to Host Virtual KOL Event on the Unmet Need in Bipolar Mania and the RAP-219 Clinical Program

Rapport Therapeutics, a clinical-stage biotech company focused on neurological and psychiatric disorders, announced a virtual key opinion leader (KOL) event for September 22, 2026, to discuss the unmet needs in treating bipolar mania and the development of its lead investigational drug RAP-219. The event will feature expert insights on the limitati…

USA Rare Earth (Nasdaq: USAR) Announces Completion of Upsized $1.55 Billion Capitalization of the U.S. Government-Backed Special Purpose Vehicle (SPV) for Serra Verde Offtake

USA Rare Earth (Nasdaq: USAR) Announces Completion of Upsized $1.55 Billion Capitalization of the U.S. Government-Backed Special Purpose Vehicle (SPV) for Serra Verde Offtake

USA Rare Earth announced the completion of capitalization of a $1.55 billion Special Purpose Vehicle backed by the U.S. Government to purchase 100% of Phase 1 production from Serra Verde, a key rare earth producer. The Department of War committed $750 million, and the Company secured a $500 million senior debt facility, underpinning the acquisition…